Search For "clinical trial"
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More
Cardiologist leads commission to help reduce burden of women's heart disea
Updated : 4 years, 10 months ago IST
New York [US], May 17 (ANI): A unique commission that issued major new recommendations aimed at fully understanding and reducing the global burden of heart disease in women was led by Roxana Mehran, MD, Professor of Medicine, and Population Health Science and Policy, and Director of Interven
Read More
Plea in SC seeks disclosure of clinical trials data for COVID-19 vaccines
Updated : 4 years, 10 months ago IST
New Delhi [India], May 14 (ANI): A plea has been filed in the Supreme Court seeking transparency in Covid-19 vaccine clinical trial and post-vaccination data, including the recording and reporting of adverse events.
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
European Medicines Agency experts beginning Sputnik V manufacturing inspec
Updated : 4 years, 10 months ago IST
Moscow [Russia], May 12 (ANI/Sputnik): Experts from the European Medicines Agency (EMA) are beginning Russia's Sputnik V COVID-19 vaccine manufacturing inspections, as they have already completed the study of clinical trials, the results of both sets of the inspections will be integrated int
Read More
Subject Expert Committee gives nod to Covaxin for Phase 2, 3 trials on chi
Updated : 4 years, 10 months ago IST
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
Read More
Switch of breast tumors to HER2-low might provide greater therapeutic opti
Updated : 4 years, 10 months ago IST
Lugano [Switzerland], May 9 (ANI): The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low t
Read More
Gene therapy shows promise for patients with congenital blindness
Updated : 4 years, 10 months ago IST
Philadelphia (Pennsylvania) [US], May 2 (ANI): A recent study's initial data from a clinical trial led by researchers found that new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision.
Read More
VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based immunological company said.
Read More
Gene therapy shows promise for patients with childhood blindness
Updated : 4 years, 10 months ago IST
Philadelphia (Pennsylvania) [US], April 25 (ANI): According to initial data from a clinical trial led by researchers, new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision.
Read More
Older adults can improve sleep quality by listening to music
Updated : 4 years, 10 months ago IST
Washington [US], April 24 (ANI): A recent analysis on all the relevant published clinical trials found that for older adults listening to music before going to sleep can improve its quality.
Read More
Johnson & Johnson trails shows vaccine effective even against variants
Updated : 4 years, 10 months ago IST
New Jersey [US], April 22 (ANI): Johnson & Johnson's single-shot coronavirus vaccine protected against symptomatic and asymptomatic infection, and prevented hospitalization and death in all participants 28 days after vaccination, according to new clinical trial results published on Wedne
Read More